- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.07. | Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month" | 348 | ACCESS Newswire | Spotlighting Two Decades of Natural Regenerative Support, Anti-Aging and Longevity Science, AI-Recognized Pioneer-Leader in Stem Cell Nutrition Marks 20 Years of All-Natural, Plant-Based Stemceuticals... ► Artikel lesen | |
| 23.06. | Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities | 372 | ACCESS Newswire | LIVE LONGER - LIVE BETTER - LIVE YOUNGERNewly Secured Inventory Funding and Global Expansion Position the Company for Scalable Growth Amid Accelerating Demand NAPLES, FL / ACCESS Newswire / June 23... ► Artikel lesen | |
| 22.06. | Stemtech Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.05. | Stemtech Corp - 10-K, Annual Report | - | SEC Filings | ||
| 14.05. | Stemtech Corp - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 07.04. | Stemtech Corporation: Stemtech Secures Inventory Funding | 622 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / April 7, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, secures funding for production of $2.5 Million of Inventory to protect against... ► Artikel lesen | |
| STEMTECH Aktie jetzt für 0€ handeln | |||||
| 31.03. | Stemtech Corp - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 18.03. | Stemtech Corporation: Stemtech Revolution 2026: A Bold New Era In Global Wellness | 248 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / March 18, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, expands Stemtech BioSciences E-Commerce Retail market channel in addition... ► Artikel lesen | |
| 26.02. | Stemtech Corporation Launches New Market Channel Biosciences Ecommerce | 428 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / February 26, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, launches Stemtech BioSciences E-Commerce Retail market channel.(Stemtech... ► Artikel lesen | |
| 03.02. | Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board | 553 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / February 3, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Zahooruddin, MBBS (MD), DAASCP to the Life Sciences... ► Artikel lesen | |
| 06.01. | Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer | 533 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / January 6, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Lizette Leos, MD to Chief Scientific Officer. (Stemtech... ► Artikel lesen | |
| 02.12.25 | Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures | 400 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / December 2, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture to... ► Artikel lesen | |
| 27.10.25 | Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry | 651 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic... ► Artikel lesen | |
| 23.10.25 | Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP | 568 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / October 23, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture... ► Artikel lesen | |
| 20.10.25 | Stemtech Corporation Backorders Filled | 654 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / October 20, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, announces core products are available for shipment after overcoming challenges... ► Artikel lesen | |
| 09.10.25 | Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement | 421 | ACCESS Newswire | NAPLES, FL / ACCESS Newswire / October 9, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce an exclusive distribution agreement with Energy International... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 49,810 | +0,83 % | DAX vor spannender Woche - und Rekorden? Bayer, Siemens Energy, Commerzbank und Allianz mit ... | Ungeachtet der geopolitischen Krisenherde könnte die überwiegend positiv aufgenommene Berichtssaison der DAX-Konzern auch in der neuen Woche Rückenwind verleihen. Sinkende Ölpreise und starke Quartalszahlen... ► Artikel lesen | |
| MERCK KGAA | 143,65 | -1,03 % | Neue Folge "Börse, Baby!": Earnings-Alarm: Jetzt entscheidet sich der KI-Boom | Die KI-Euphorie bekommt erste Risse: Trotz starker Quartalszahlen geraten Tech-Aktien kräftig unter Druck. Ist das noch eine gesunde Korrektur? Die Berichtssaison zeigt derzeit, wie hoch die Erwartungen... ► Artikel lesen | |
| NOVO NORDISK | 40,970 | -0,06 % | Novo Nordisk, Johnson & Johnson und Co. setzen auf Plattformen - warum einzelne Medikamente für Big Pharma längst nicht mehr ausreichen | ||
| PFIZER | 23,100 | -0,15 % | Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound | ||
| BRIGHT MINDS BIOSCIENCES | 79,33 | 0,00 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| ELI LILLY | 1.027,40 | +0,21 % | Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem | ||
| ZHENGYE BIOTECHNOLOGY | 1,890 | 0,00 % | Zhengye Biotechnology regains Nasdaq bid price compliance; shares down | ||
| ETON PHARMACEUTICALS | 44,560 | -0,09 % | Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 | ASN-001 targets the substantially larger population of moderate infantile hemangiomas currently treated off-label with topical timololComplementary product to HEMANGEOL (propranolol hydrochloride)... ► Artikel lesen | |
| SANOFI | 75,42 | -0,08 % | BERENBERG stuft SANOFI auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Sanofi auf "Buy" mit einem Kursziel von 105 Euro belassen. Angesichts der Stärke des Portfolios von bereits auf dem Markt... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,880 | -0,04 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| OMNIAB | 3,080 | 0,00 % | OmniAb GAAP EPS of -$0.05 beats by $0.07, revenue of $13.4M beats by $8.71M | ||
| LB PHARMACEUTICALS | 47,960 | -0,08 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Announces $150 Million Private Placement | NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact... ► Artikel lesen | |
| CANOPY GROWTH | 0,841 | -0,10 % | Canopy Growth übertrifft Gewinnerwartungen für Q1 2027 - Aktie legt zu | ||
| SCHOTT PHARMA | 22,500 | +2,74 % | UBS stuft Schott Pharma auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Schott Pharma von 25,90 auf 26,50 Euro angehoben und die Einstufung auf "Buy" belassen. Das neue Kursziel reflektiere den... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,945 | +0,13 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Reaffirms guidance to resubmit Anaphylm (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union... ► Artikel lesen |
STEMTECH CORPORATION gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STEMTECH CORPORATION finden Sie auf Wallstreet Online.